Technology News and Research

RSS

Health IT roundup: Buyers' remorse, usage survey

Huffington Post Investigative Fund: The federal government has made investing in electronic medical records a priority by channeling billions of dollars to help doctors and hospitals go paperless, "[b]ut there's also concern that the government may not be doing enough to ensure that taxpayer money isn't wasted on faulty systems. What's more, doctors often have little expertise in buying electronic health records, commonly called EHRs, and do not always know what questions to ask or what protections they should push for in their contracts, several industry consultants said in interviews."

2 Feb 2010

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

Canadian families managing Attention Deficit Hyperactivity Disorder (ADHD) have a new treatment option. Today, Shire plc, the global specialty biopharmaceutical company, announced the Canadian availability of VYVANSE (lisdexamfetamine dimesylate capsule), the first and only prodrug therapy approved for ADHD treatment in Canada.

2 Feb 2010

DATATRAK International announces multi-center study on Renal Anemia

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the contract signing for a Phase IV, eight-year, 500-site, 5,000-patient study worth approximately $900,000 with a global specialty pharmaceutical and medication delivery company.

2 Feb 2010

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that the Australian Government Department of Health and Ageing Therapeutic Goods Administration has approved the CT Laser Mammography (CTLM®) system for inclusion on the Australian Register of Therapeutic Goods (ARTG).

2 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

YM BioSciences-Cytopia merger complete

YM BioSciences Inc., announced that the merger of Cytopia Limited, the Australian biopharmaceutical company, into YM under a Scheme of Arrangement, has been concluded.

1 Feb 2010

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that the National Institutes of Health (NIH) awarded a grant to the University of Pittsburgh that includes funding of $350,000 over the grant period for WaferGen's SmartChip™ Real-Time PCR System. The researchers will conduct novel gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system as the key platform for high throughput validation.

1 Feb 2010

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

Managing Myeloma (www.ManagingMyeloma.com) convened the 2010 Multidisciplinary Advisory Board on January 16, 2010 to review the past 18 months and discuss the educational and practical needs of myeloma practitioners in an evolving therapeutic landscape.

1 Feb 2010

New testing method for early detection of cancer

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed.

1 Feb 2010

QHN expands to the Western Colorado communities of Aspen and Montrose

Quality Health Network (QHN), one of the most celebrated and successful health information exchanges (HIE) in the country, and Axolotl Corp., the nationwide leader in HIE solutions and services, are pleased to announce QHN’s successful expansion to the Western Colorado communities of Aspen and Montrose.

1 Feb 2010

Piraeus Bank licenses Misys BankFusion Equation as technology platform to underpin expansion plans

Misys plc, the global application software and services company, today announces that Piraeus Bank, the Athens-based universal bank, has licensed Misys BankFusion Equation as the technology platform to underpin its expansion plans.

1 Feb 2010

Oxford Nanopore Technologies raises $28M in new funding

Oxford Nanopore Technologies Ltd., a privately held company that is developing a disruptive technology platform for the electronic, label-free analysis of single molecules, today announced that it has raised £17.4 million ($28 million) in new funding.

From Oxford Nanopore Technologies 1 Feb 2010

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reported today its sales for the fourth quarter and full year 2009.

1 Feb 2010

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen.

1 Feb 2010

NCD releases January 2010 monthly bulletin

NCD released its latest report on housing entitled The State of Housing in America in the 21st Century: A Disability Perspective, which provides recommendations to improve housing opportunities for people with disabilities.

1 Feb 2010

Optimed appoints Menicon as exclusive distributor for Japan and Taiwan

Optimed Ltd. and Menicon Co., Ltd. announced on January 26 the expansion of Optimed products into the Asia market by the appointment of Menicon as exclusive distributor for Japan and Taiwan.

1 Feb 2010

University of Kentucky and Manipal University pursue opportunities for health center alliance

University of Kentucky administrators welcomed Dr. Rajasekharan Warrier, Vice Chancellor of Manipal University, to campus with hopes of pursuing opportunities for comprehensive collaboration between the two universities.

31 Jan 2010

UK plastic surgery industry experiences significant growth

The US may have experienced a 12% decrease in the number of surgical and non-surgical cosmetic treatments, but the British Association of Aesthetic Plastic Surgeons have a different story to tell. They found the UK experienced a 5% increase in demand from 2007 to 2008, and a 9% increase from 2008 to 2009.

31 Jan 2010

Humedica to participate in 7th Annual Healthcare Conference

Humedica, a next-generation clinical informatics company, today announced that it will be presenting at Harvard Business School’s 7th Annual Healthcare Conference: “Policy Reform: An Inflection Point for Healthcare Management?” on Saturday, January 30, 2010.

30 Jan 2010

Technology News and Research

Health IT roundup: Buyers' remorse, usage survey

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

DATATRAK International announces multi-center study on Renal Anemia

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Thermo Fisher Scientific to acquire Finnzymes

YM BioSciences-Cytopia merger complete

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

New testing method for early detection of cancer

QHN expands to the Western Colorado communities of Aspen and Montrose

Piraeus Bank licenses Misys BankFusion Equation as technology platform to underpin expansion plans

Oxford Nanopore Technologies raises $28M in new funding

Ipsen reports consolidated group sales of €1,032.8M for 2009

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

NCD releases January 2010 monthly bulletin

Optimed appoints Menicon as exclusive distributor for Japan and Taiwan

University of Kentucky and Manipal University pursue opportunities for health center alliance

UK plastic surgery industry experiences significant growth

Humedica to participate in 7th Annual Healthcare Conference

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News